Nancy J. Cox
#120,168
Most Influential Person Now
Nancy J. Cox's AcademicInfluence.com Rankings
Nancy J. Coxphilosophy Degrees
Philosophy
#5412
World Rank
#8204
Historical Rank
Logic
#2699
World Rank
#3729
Historical Rank

Nancy J. Coxbiology Degrees
Biology
#7229
World Rank
#10121
Historical Rank
Genetics
#685
World Rank
#771
Historical Rank

Download Badge
Philosophy Biology
Nancy J. Cox's Degrees
- PhD Human Genetics University of Chicago
- Doctorate Medicine University of Chicago
Why Is Nancy J. Cox Influential?
(Suggest an Edit or Addition)Nancy J. Cox's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A novel coronavirus associated with severe acute respiratory syndrome. (2003) (4084)
- MORTALITY ASSOCIATED WITH INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS IN THE UNITED STATES (2002) (3656)
- Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2004) (2557)
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans (2009) (2458)
- Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2006) (2456)
- Influenza-associated hospitalizations in the United States. (2004) (2179)
- Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. (1998) (1404)
- Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. (2009) (1301)
- Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus (2005) (1203)
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses (2009) (1149)
- Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009) (1047)
- A distinct lineage of influenza A virus from bats (2012) (1028)
- Influenza surveillance--United States, 1992-93 and 1993-94. (1997) (985)
- Probable person-to-person transmission of avian influenza A (H5N1). (2005) (865)
- Global epidemiology of influenza: past and present. (2000) (833)
- Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays (1999) (831)
- Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. (2010) (764)
- Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern (2005) (741)
- Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. (1998) (721)
- The Global Circulation of Seasonal Influenza A (H3N2) Viruses (2008) (692)
- Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. (1999) (690)
- Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. (2000) (687)
- The economic impact of pandemic influenza in the United States: priorities for intervention. (1999) (677)
- Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. (2006) (672)
- Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice (2009) (665)
- Influenza-associated deaths among children in the United States, 2003-2004. (2005) (637)
- Transmission of Equine Influenza Virus to Dogs (2005) (624)
- Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. (2000) (618)
- Structural basis of immune recognition of influenza virus hemagglutinin. (1990) (577)
- A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission (2007) (552)
- Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. (2010) (544)
- Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2002) (539)
- Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. (2007) (535)
- Predicting the evolution of human influenza A. (1999) (518)
- The impact of influenza epidemics on hospitalizations. (2000) (500)
- Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals (2005) (482)
- Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. (2009) (442)
- A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans (1999) (412)
- Global circulation patterns of seasonal influenza viruses vary with antigenic drift (2015) (402)
- Evolution of H5N1 Avian Influenza Viruses in Asia (2005) (383)
- Long term trends in the evolution of H(3) HA1 human influenza type A. (1997) (383)
- Comparisons of Highly Virulent H5N1 Influenza A Viruses Isolated from Humans and Chickens from Hong Kong (1998) (367)
- Three Indonesian clusters of H5N1 virus infection in 2005. (2006) (347)
- Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. (2013) (341)
- Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model (2006) (340)
- Positive selection on the H3 hemagglutinin gene of human influenza virus A. (1999) (327)
- Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. (2000) (318)
- Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites (1983) (313)
- Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. (2002) (308)
- Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. (1999) (298)
- Prevention and control of influenza (1999) (283)
- Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. (2003) (264)
- Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. (1999) (261)
- Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. (2000) (248)
- Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. (2008) (246)
- Isolation and Characterization of Avian Influenza Viruses, Including Highly Pathogenic H5N1, from Poultry in Live Bird Markets in Hanoi, Vietnam, in 2001 (2005) (236)
- Seasonal influenza vaccines. (2009) (229)
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season (2014) (228)
- Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. (2008) (221)
- Global concerns regarding novel influenza A (H7N9) virus infections. (2013) (219)
- Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. (1995) (198)
- Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. (2012) (195)
- Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. (1995) (192)
- In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. (2012) (190)
- Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. (1993) (182)
- Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. (2009) (182)
- Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. (2006) (180)
- Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. (1998) (178)
- Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. (1999) (176)
- Serologic Evidence of H1 Swine Influenza Virus Infection in Swine Farm Residents and Employees (2002) (171)
- Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. (2004) (168)
- Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season. (2010) (166)
- Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. (2002) (165)
- Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013 (2013) (161)
- Genetic Compatibility and Virulence of Reassortants Derived from Contemporary Avian H5N1 and Human H3N2 Influenza A Viruses (2008) (160)
- The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. (1986) (158)
- Outbreak of Variant Influenza A(H3N2) Virus in the United States (2013) (150)
- Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. (2007) (148)
- Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). (1988) (138)
- Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. (2007) (132)
- Estimated Influenza Illnesses and Hospitalizations Averted by Vaccination — United States, 2013–14 Influenza Season (2014) (132)
- Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans * (2002) (131)
- Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2004) (130)
- Experimental Evaluation of the FluChip Diagnostic Microarray for Influenza Virus Surveillance (2006) (128)
- Evolution of Highly Pathogenic H5N1 Avian Influenza Viruses in Vietnam between 2001 and 2007 (2008) (124)
- Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. (2000) (121)
- Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets (2012) (121)
- The molecular epidemiology of influenza viruses (1995) (120)
- Low incidence of rimantadine resistance in field isolates of influenza A viruses. (1999) (116)
- Reassortment between Avian H5N1 and Human H3N2 Influenza Viruses in Ferrets: a Public Health Risk Assessment (2009) (116)
- Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). (2003) (115)
- Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. (2008) (113)
- Family Clustering of Avian Influenza A (H5N1) (2005) (113)
- The total influenza vaccine failure of 1947 revisited: Major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic (2002) (109)
- Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. (2006) (106)
- Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. (2011) (103)
- Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. (1993) (102)
- The development of vaccine viruses against pandemic A(H1N1) influenza. (2011) (101)
- Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza (1989) (100)
- Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 1999 (2002) (99)
- Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child (1991) (96)
- WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. (2014) (95)
- Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: Divergence of clade 2·2 viruses (2009) (94)
- Influenza Activity — United States, 2013–14 Season and Composition of the 2014–15 Influenza Vaccines (2014) (92)
- Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. (2000) (91)
- Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013 (2013) (91)
- 17 – Inactivated influenza vaccines (2013) (90)
- Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. (2000) (89)
- An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza (1994) (87)
- Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). (2011) (87)
- The occurrence of hepatitis A and astroviruses in selected river and dam waters in South Africa. (2001) (87)
- Influenza Activity — United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine (2013) (86)
- Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. (2011) (86)
- Avian-to-human transmission of H 9 N 2 subtype influenza A viruses : Relationship between H 9 N 2 and H 5 N 1 human isolates (2000) (85)
- Influenza pandemic planning. (2003) (85)
- Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (2010) (83)
- Reassortment and evolution of current human influenza A and B viruses. (2004) (83)
- Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. (1979) (83)
- A Method for Timely Assessment of Influenza‐Associated Mortality in the United States (1997) (82)
- Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren. (1996) (82)
- Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin (2013) (81)
- Effect of D222G Mutation in the Hemagglutinin Protein on Receptor Binding, Pathogenesis and Transmissibility of the 2009 Pandemic H1N1 Influenza Virus (2011) (81)
- Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. (2000) (79)
- Recombination of human influenza A viruses in nature (1980) (79)
- Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. (2008) (78)
- Updated preparedness and response framework for influenza pandemics. (2014) (78)
- Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2013) (76)
- Transmission and Pathogenesis of Swine-Origin 2009 A ( H 1 N 1 ) Influenza Viruses in Ferrets and Mice Citation (2010) (76)
- Influenza A Virus Nucleoprotein Exploits Hsp40 to Inhibit PKR Activation (2011) (76)
- Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. (2015) (75)
- Influenza pandemic preparedness plan for the United States. (1997) (74)
- Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. (2001) (72)
- Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. (2011) (71)
- Highly Pathogenic Avian Influenza A(H7N3) Virus in Poultry Workers, Mexico, 2012 (2013) (69)
- Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay (1995) (69)
- MChip: a tool for influenza surveillance. (2006) (68)
- Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA. (1983) (68)
- Pathogenesis, Transmissibility, and Ocular Tropism of a Highly Pathogenic Avian Influenza A (H7N3) Virus Associated with Human Conjunctivitis (2013) (68)
- Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. (1995) (68)
- Influenza A virus infection complicated by fatal myocarditis. (2000) (67)
- Antigenic and Genetic Diversity of Highly Pathogenic Avian Influenza A (H5N1) Viruses Isolated in Egypt (2010) (67)
- Identification of A/H5N1 influenza viruses using a single gene diagnostic microarray. (2007) (66)
- WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. (2012) (66)
- Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus. (1988) (66)
- 65 years of influenza surveillance by a World Health Organization‐coordinated global network (2018) (65)
- Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. (2003) (65)
- The first confirmed human case of avian influenza A (H5N1) in Mainland China (2006) (65)
- Human influenza A (H1N2) viruses isolated from China. (1992) (65)
- SURVEILLANCE FOR INFLUENZA - UNITED STATES, 1997–98, 1998–99, AND 1999–00 SEASONS (2002) (64)
- Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. (2003) (63)
- Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). (2014) (62)
- Pandemic Influenza Planning, United States, 1978–2008 (2013) (61)
- Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus. (1992) (61)
- Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. (1996) (61)
- Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season. (2002) (59)
- Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. (2009) (59)
- Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. (1989) (58)
- Selection of antigenically advanced variants of seasonal influenza viruses (2016) (57)
- Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2011) (56)
- PCR restriction analysis of genome composition and stability of cold-adapted reassortant live influenza vaccines. (1995) (56)
- Structural Stability of Influenza A(H1N1)pdm09 Virus Hemagglutinins (2014) (55)
- Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. (2006) (54)
- Estimated Influenza Illnesses and Hospitalizations Averted by Influenza Vaccination — United States, 2012–13 Influenza Season (2013) (54)
- Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. (1984) (54)
- Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers (1981) (53)
- Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014. (2015) (53)
- Surveillance for influenza--United States, 1994-95, 1995-96, and 1996-97 seasons. (2000) (52)
- Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. (2009) (51)
- Development of Framework for Assessing Influenza Virus Pandemic Risk (2015) (50)
- Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults (2008) (49)
- Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. (2012) (49)
- Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. (2007) (49)
- Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. (1983) (48)
- Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. (1983) (47)
- Update: influenza activity--United States, August 30, 2009-January 9, 2010. (2010) (46)
- Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. (1993) (46)
- A Global Lab Against Influenza (2001) (43)
- Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins (2016) (43)
- Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2005) (42)
- Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems (2009) (42)
- Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2003) (42)
- The Wilhelmine E. Key 1999 Invitational lecture. Predicting the evolution of human influenza A. (2000) (42)
- Pause on avian flu transmission research. (2012) (41)
- Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. (2011) (41)
- Divergent seasonal patterns of influenza types A and B across latitude gradient in Tropical Asia (2016) (40)
- H7N9: preparing for the unexpected in influenza. (2015) (40)
- Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980 (1981) (40)
- Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α‐actinin‐4 for viral replication (2014) (40)
- Influenza seasonality: timing and formulation of vaccines. (2014) (39)
- Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. (1984) (38)
- Influenza: Global surveillance for epidemic and pandemic variants (1994) (38)
- Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (1993) (38)
- Development of an Influenza Virologic Risk Assessment Tool (2012) (38)
- Robust Sequence Selection Method Used To Develop the FluChip Diagnostic Microarray for Influenza Virus (2006) (37)
- Preparing for pandemic influenza: the need for enhanced surveillance. (2002) (37)
- Transmission Studies Resume for Avian Flu (2013) (37)
- Influenza A(H1N1)pdm09 Virus among Healthy Show Pigs, United States (2012) (37)
- Update: influenza activity - United States, August 30-October 31, 2009. (2009) (36)
- Diagnostic microarray for influenza B viruses. (2007) (35)
- Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates. (1990) (35)
- Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. (1995) (34)
- Multiplication of influenza virus in the presence of cordycepin, an inhibitor of cellular RNA synthesis. (1973) (34)
- Evaluation of the Subtype Specificity of Monoclonal Antibodies Raised against H1 and H3 Subtypes of Human Influenza A Virus Hemagglutinins (2002) (32)
- Pause on Avian Flu Transmission Research (2012) (32)
- Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004 (2009) (31)
- Identification of Molecular Markers Associated with Alteration of Receptor-Binding Specificity in a Novel Genotype of Highly Pathogenic Avian Influenza A(H5N1) Viruses Detected in Cambodia in 2013 (2014) (31)
- Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus. (1988) (31)
- Influenza A Virus Neuraminidase Protein Enhances Cell Survival through Interaction with Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) Protein* (2012) (30)
- Detection and Characterization of Clade 7 High Pathogenicity Avian Influenza H5N1 Viruses in Chickens Seized at Ports of Entry and Live Poultry Markets in Vietnam (2010) (30)
- Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. (1997) (30)
- Influenza: virology, epidemiology, disease, and prevention. (1994) (30)
- Genetic approaches to attenuation of influenza A viruses for man. (1980) (29)
- Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. (2008) (29)
- Human influenza: One health, one world (2013) (29)
- Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry. (2011) (29)
- Pathogenicity and antigenicity of a new influenza a (H5N1) virus isolated from duck meat (2003) (27)
- Update: influenza activity - United States, September 28, 2008--January 31, 2009. (2009) (26)
- Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine production (2009) (24)
- Inactivated and live attenuated influenza vaccines in young children--how do they compare? (2007) (23)
- Molecular epidemiology of influenza A(H3N2) virus reinfections. (2002) (23)
- Update: Influenza Activity — United States, September 28–December 6, 2014 (2014) (23)
- Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011. (2013) (23)
- Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: independent segregation of temperature-sensitivity of virus replication from temperature-sensitivity of virion transcriptase activity during recombination of mutant A/Ann Arbor/6/60 with wild-type H3N2 strain (1979) (23)
- Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs (2015) (23)
- Biological, genetic and biochemical characterization of a cold-adapted recombinant A/Victoria/3/75 virus and its evaluation in volunteers. (1977) (21)
- Comparative studies of wild-type and 'cold-mutant' (temperature sensitive) influenza viruses: geneology of the matrix (M) and non-structural (NS) proteins in recombinant cold-adapted H3N2 viruses. (1977) (21)
- Preparing for pandemic influenza: the need for enhanced surveillance. (1999) (21)
- New options for the prevention of influenza. (1999) (21)
- Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness (2014) (20)
- Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance. (1997) (20)
- INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012. (2013) (20)
- Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 (2013) (20)
- Presence of a segmented single-stranded RNA genome in influenza C virus. (1976) (19)
- Severe influenza among children and young adults with neurologic and neurodevelopmental conditions - Ohio, 2011. (2012) (19)
- Influenza surveillance--United States, 1991-92. (1992) (19)
- Update: Influenza Activity — United States, September 29, 2013–February 8, 2014 (2014) (19)
- Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. (1994) (19)
- Influenza--United States, 1989-90 and 1990-91 seasons. (1992) (19)
- Emergence and Transmission of Amantadine‐Resistant Influenza A in a Nursing Home (2004) (19)
- Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus (2001) (19)
- Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs (2015) (18)
- A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004–2014 (2019) (17)
- Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain. (1986) (17)
- DEVELOPMENT OF COLD RECOMBINANTS OF INFLUENZA VIRUS AS LIVE VIRUS VACCINES (1981) (16)
- Prevention and control of influenza. (1986) (16)
- Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants. (1993) (15)
- Influenza vaccination among the elderly in the United States. (2005) (15)
- Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014. (2015) (14)
- Comparative studies of A/Leningrad/134/57 wild-type and 47-times passaged cold-adapted mutant influenza viruses: oligonucleotide mapping and RNA-RNA hybridization studies. (1985) (14)
- Modeling the effects of updating the influenza vaccine on the efficacy of repeated vaccination (2000) (14)
- Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 department of health and human services Centers for Disease Control and Prevention (2009) (14)
- Public Health Implications of Avian Influenza Viruses (2009) (14)
- Adamantane-Resistant Influenza Infection During the 2004–05 Season (2008) (14)
- Safety Evaluation in Chickens of Candidate Human Vaccines Against Potential Pandemic Strains of Influenza (2003) (14)
- Update: Influenza activity--United States, 2002-03 season. (2003) (13)
- Genetic relatedness between influenza A (H1N1) viruses isolated from humans and pigs. (1994) (13)
- Replication of animal viruses in differentiating muscle cells: influenza virus A. (1977) (13)
- Evaluation of MChip with Historic Subtype H1N1 Influenza A Viruses, Including the 1918 “Spanish Flu” Strain (2007) (13)
- GENETIC AND BIOCHEMICAL ANALYSIS OF THE A/ANN ARBOR/6/60 COLD-ADAPTED MUTANT (1981) (12)
- Generation and Characterization of an H9N2 Cold-Adapted Reassortant as a Vaccine Candidate (2003) (12)
- Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model (2014) (12)
- Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2000) (12)
- Effect of D 222 G Mutation in the Hemagglutinin Protein on Receptor Binding , Pathogenesis and Transmissibility of the 2009 Pandemic H 1 N 1 Influenza Virus (2011) (12)
- Capacity Building in Response to Pandemic Influenza Threats: Lao PDR Case Study (2012) (12)
- 31 – Inactivated Influenza Vaccines (2018) (11)
- Forecasting the epidemic potential of influenza virus variants based on their molecular properties. (1985) (11)
- Multiple lineages co-circulation and genetic reassortment of the neuraminidase and hemagglutinin genes within influenza viruses of the same type/subtype (2001) (10)
- The first confirmed human case of avian influenza A (H5N1) in Mainland China. (2006) (10)
- ErratumErratum to “In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity” [Virology 422 (2011) 105–113] (2012) (10)
- Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015 (2018) (9)
- Public health implications of animal influenza viruses (2016) (8)
- Influenza activity --- United States and worldwide, June 13-September 25, 2010. (2010) (8)
- Recommendations of the 7th European Meeting of Influenza and Its Prevention (1994) (8)
- Prevention and control of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP); Vaccines; Part I (1994) (8)
- Decreased antibody response among nursing home residents who received recalled influenza vaccine and results of revaccination, 1996-97. (2000) (8)
- Prevention and control of influenza; Part II, Antiviral agents : recommendations of the Advisory Committee on Immunization Practices (ACIP) (1994) (7)
- Seven integrated influenza surveillance systems in Taiwan (2001) (7)
- Update: influenza activity--United States, 2004-05 season. (2005) (7)
- New England Medical Journal (2007) (7)
- Oligonucleotide mapping of viral ribonucleic acid as an aid in identifying laboratory contaminants of influenza virus. (1986) (6)
- Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978 (1980) (6)
- Predicting influenza evolution: the impact of terminal and egg-adapted mutations (2001) (6)
- Reassortment between avian apathogenic and human attenuated cold-adapted viruses as an approach for preparing influenza pandemic vaccines (2004) (6)
- Pathogenesis of and Immunity to a New Influenza A (H5N1) Virus Isolated from Duck Meat (2003) (6)
- Panel summary of international pandemic influenza plans. (1997) (6)
- NATURAL AND UNNATURAL VARIATION IN INFLUENZA A(H1N1) VIRUSES SINCE 1977 (1981) (6)
- Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription. (2020) (6)
- Hybridization studies of the relationship between influenza virus RNA and cellular DNA. (1976) (5)
- Nucleotide sequences of the neuraminidase genes of influenza A/Leningrad/134/57 (H2N2) virus and two of its live, attenuated, cold-adapted variants (2005) (5)
- Complex Simplicity and Hirschsprung's Disease. (2019) (5)
- Alternative models for estimating influenza-attributable P&I deaths in the US (2001) (5)
- Influenza surveillance in poultry market and its inter-species transmission in Taiwan (2001) (4)
- Update: influenza activity --- United States, October 3-December 11, 2010. (2010) (4)
- Influenza--United States, 1988-89. (1993) (4)
- Replication of animal viruses in differentiating muscle cells: vaccinia and herpes simplex virus type 1. (1978) (4)
- Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillance. (1998) (4)
- Evolutionary analysis of human H2N2 and early H3N2 influenza viruses: evidence for genetic divergence and multiple reassortment among H2N2 and/or H3N2 viruses (2004) (4)
- Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) Prepared by (2005) (4)
- Update: Influenza Activity — United States, September 29–December 7, 2013 (2013) (4)
- Effect of temperature on the order of electrophoretic migration of influenza virus neuraminidase and nucleoprotein genes in acrylamide gels lacking denaturing agents. (1978) (4)
- Antigenic and Genetic Variation of Influenza A(H1N1) Viruses (1990) (4)
- Update: Influenza Activity — United States and Worldwide, May 18–September 20, 2014 (2014) (4)
- [Formation of humoral and secretory immunity in elderly persons with different schemes of immunization with flu vaccines]. (1998) (3)
- Update: Influenza Activity — United States, September 30, 2012–February 9, 2013 (2013) (3)
- Antigenic characteristics of recent avian influenza A H5N1 viruses isolated from humans (2004) (3)
- Development of candidate H7N3 live attenuated influenza vaccine (2008) (3)
- Influenza surveillance with rapid diagnostic tests. (2002) (3)
- Age-specific estimates of US influenza-associated deaths and hospitalizations (2004) (3)
- Influenza pandemic plan: integrated wild bird/domestic avian/swine/human flu surveillance systems in Taiwan (2004) (3)
- Influenza pandemic planning: review of a collaborative state and national process (2001) (3)
- Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age (2001) (3)
- Prospecting the influenza hemagglutinin to develop universal vaccines. (2011) (3)
- Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected (2022) (2)
- Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2013 (2013) (2)
- Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Commentary (2006) (2)
- So many questions, so little time. (2013) (2)
- Options for the control of influenza IV : proceedings of the World Congress on Options for the Control of Influenza IV held in Crete, Greece, 23rd-28th September 2000 (2001) (2)
- Pandemic Virus Characterization of the Reconstructed 1918 Spanish Influenza (2012) (2)
- A protein network of one's own proteins (2005) (2)
- [Vaccination against influenza in children with acute lymphoblastic leukemia]. (1996) (2)
- [In vitro proliferative activity of lymphocytes from elderly persons after separate and combined immunization with live and inactivated flu vaccines]. (2000) (2)
- [Production of interleukin-2 in vitro and in vivo in elderly people, vaccinated with live and inactivated flu vaccines separately and combined]. (2000) (2)
- XIth International Symposium on Respiratory Viral Infections (2011) (1)
- Human influenza surveillance in areas with animal flu epidemics and China visitors in Taiwan (2004) (1)
- Shift Shown in Influenza A Adamantane Resistance—Reply (2006) (1)
- Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2008 department of health and human services Centers for Disease Control and Prevention (2008) (1)
- [Influenza vaccination of children with hemophilia]. (1995) (1)
- Molecular epidemiology of influenza virus isolated in Brazil from 1996 to 2000 (2004) (1)
- Infectious Disease and Host–Pathogen Evolution: Influenza Evolution (2004) (1)
- ANTIGENIC DRIFT OF THE H1 SUBTYPE HAEMAGGLUTININ FROM 1977 TO 1980 (1984) (1)
- Genome evolution of human epidemic influenza viruses (1988) (1)
- Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (2010) (1)
- GENETIC STABILITY OF A/ANN ARBOR/6/60 COLD-MUTANT (TEMPERATURE-SENSITIVE) LIVE INFLUENZA VACCINE STRAINS (1984) (1)
- J. Virol. Methods (1995) (1)
- The detection of hepatitis A and astroviruses in river and dam water (2000) (0)
- Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 Prepared by (2009) (0)
- Morbidity and Mortality Weekly Report (2003) (0)
- New approaches to large-scale data integration: Across-omics and across variant types (2014) (0)
- Update: Influenza Activity--United States, 2004-05 Season: (401052005-006) (2013) (0)
- Prevention and control of influenza. (1999) (0)
- Crystal Structure of the Hemagglutinin from a H1N1pdm A/WASHINGTON/5/2011 virus (2014) (0)
- [Immune response of elderly persons depending on the number of annual seasonal immunizations of live and inactivated influenza vaccines]. (1998) (0)
- , David A ( H 1 N 1 ) pdm 09 Virus Hemagglutinins Structural Stability of Influenza (2014) (0)
- Production of interleukin-2 in vitro and in vivo in elderly subjects vaccinated with live and inactivated influenza vaccines and their combination. (2000) (0)
- Shift shown in influenza a Adamantane resistance. Authors' reply (2006) (0)
- Antibody response to a sub-potent influenza vaccine among nursing home residents and results of revaccination, New York, 1996-97 (1997) (0)
- Comparisons with other data sets Health outcomes : Hospitalizations Non-high risk : High risk : Comparisons with other data sets : (2019) (0)
- Receptor Specificity of Influenza A H3N2 Viruses Isolated in Mammalian Cells and Embryonated Chicken Eggs (cid:1) (2010) (0)
- Genetic and antigenic analysis of the neuraminidase of influenza B viruses: association of neuraminidase in global spread and recycling of influenza B/Victoria/2/87-like viruses (2004) (0)
- INFLUENZA A VIRUS NEURAMINIDASE PROTEIN ENHANCES CELL SURVIVAL THROUGH INTERACTION WITH CEACAM6 (2012) (0)
- Crystal structure of influenza hemagglutinin (H5) in complex with a broadly neutralizing antibody F10 (2009) (0)
- Influenza present: the impact of the 1999–2000 epidemic on morbidity and mortality in the USA (2001) (0)
- Detection and Characterization of Clade 7 High Pathogenicity Avian Influenza H5N1 Viruses in Chickens Seized at Ports of Entry and Live Poultry Markets in Vietnam (2010) (0)
- Influenza pandemic vaccines: the imminent challenges from a technical and regulatory perspective (2004) (0)
- Antigenic and Genetic Diversity of Highly Pathogenic Avian Influenza A (H5N1) Viruses Isolated in Egypt (2010) (0)
- An Action Plan for improving international influenza surveillance (2004) (0)
- Vaccines against avian influenza A H9N2 viruses (2001) (0)
- Persistent influenza infection of a child with severe combined immunodeficiency syndrome (1985) (0)
- Imported Tickborne Relapsing Fever, France (2005) (0)
- The CDC's recommendations for preventing and controlling influenza (2002) (0)
- Development and evaluation of candidate influenza a vaccines for pandemic preparedness (2004) (0)
- Genetic and Antigenic Characterization of Avian Influenza A (H5N1) Viruses Isolated from Humans in Mainland China (2008) (0)
- Generation of candidate H5N1 and H9N2 influenza vaccines for pandemic preparedness (2001) (0)
- rapidinfluenza viruses in clinical specimens by Type-and subtype-specific detection of (1994) (0)
- Memoranda IMemorandums Cell culture asasubstrate fortheproduction of influenza vaccines: MemorandumfromaWHO meeting* (1995) (0)
- [Analysis of the antigenic structure of influenza A/USSR/90/77 virus hemagglutinin]. (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nancy J. Cox?
Nancy J. Cox is affiliated with the following schools: